Atrion Corporation  

(Public, NASDAQ:ATRI)   Watch this stock  
Find more results for ATRI
221.06
-0.90 (-0.41%)
Jun 19 - Close
NASDAQ real-time data - Disclaimer
Currency in USD
Range 219.34 - 222.14
52 week 185.16 - 226.99
Open 219.34
Vol / Avg. 2,347.00/1,936.00
Mkt cap 445.66M
P/E 17.96
Div/yield 0.56/1.01
EPS 12.31
Shares 2.02M
Beta 0.77
Inst. own 48%
Aug 7, 2013
Q2 2013 Atrion Corp Earnings Release Add to calendar
May 23, 2013
Atrion Corp Annual Shareholder Meeting
May 10, 2013
Q1 2013 Atrion Corp Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q1 (Mar '13) 2012
Net profit margin 19.81% 19.85%
Operating margin 28.07% 28.24%
EBITD margin - 34.63%
Return on average assets 16.75% 14.87%
Return on average equity 19.39% 17.29%
Employees 459 -
Carbon Disclosure Rating - -

Address

One Allentown Parkway
ALLEN, TX 75002-4211
United States - Map
+1-972-3909800 (Phone)
+1-972-3967581 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Discussion Group - Google Finance

Description

Atrion Corporation (Atrion), and its subsidiaries, develop and manufacture products, primarily for medical applications. The Company�s medical products range from fluid delivery devices to ophthalmic and cardiovascular products. During the year ended December 31, 2011, the Company�s fluid delivery products accounted for 38% of the Company�s revenues. These products include valves that promote infection control and needle safety. The Company has developed a variety of luer syringe check valves and one-way valves designed to fill, hold and release controlled amounts of fluids or gasses on demand for use in various intubation, catheter and other applications. The Company also makes tubing clamps in a variety of materials and colors that are compatible with various grades of tubing and sterilization processes, and produce specialized intravenous sets for use in numerous applications, including anesthesia and oncology.

Officers and directors

Emile A. Battat Chairman of the Board
Age: 74
Bio & Compensation  - Reuters
David A. Battat President, Chief Executive Officer
Age: 43
Bio & Compensation  - Reuters
Jeffery Strickland Chief Financial Officer, Vice President, Treasurer, Secretary
Age: 54
Bio & Compensation  - Reuters
Roger F. Stebbing Lead Independent Director
Age: 71
Bio & Compensation  - Reuters
Hugh J. Morgan Jr. Independent Director
Age: 83
Bio & Compensation  - Reuters
Ronald N. Spaulding Independent Director
Age: 48
Bio & Compensation  - Reuters
John P. Stupp Jr. Independent Director
Age: 62
Bio & Compensation  - Reuters